Reply to: Hippo signalling maintains ER expression and ER+ breast cancer growth
Crossref DOI link: https://doi.org/10.1038/s41586-020-03132-4
Published Online: 2021-03-03
Published Print: 2021-03-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Britschgi, Adrian
Couto, Joana Pinto
Bentires-Alj, Mohamed http://orcid.org/0000-0001-6344-1127
Text and Data Mining valid from 2021-03-03
Version of Record valid from 2021-03-03
Article History
First Online: 3 March 2021
Competing interests
: A.B. is an employee of Roche Pharma AG and J.P.C. of Novartis. M.B.-A. and A.B. are inventors on the US patent WO2016046768A1 ‘Lats and breast cancer’.